Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Retained Earnings: 2009-2024

Historic Retained Earnings for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $7.2 billion.

  • UNITED THERAPEUTICS's Retained Earnings rose 18.37% to $8.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 billion, marking a year-over-year increase of 18.37%. This contributed to the annual value of $7.2 billion for FY2024, which is 19.83% up from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Retained Earnings is $7.2 billion, which was up 19.83% from $6.0 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Retained Earnings ranged from a high of $7.2 billion in FY2024 and a low of $3.8 billion during FY2020.
  • Moreover, its 3-year median value for Retained Earnings was $6.0 billion (2023), whereas its average is $6.1 billion.
  • Data for UNITED THERAPEUTICS's Retained Earnings shows a peak YoY rose of 19.83% (in 2024) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Retained Earnings (Yearly) stood at $3.8 billion in 2020, then climbed by 12.39% to $4.3 billion in 2021, then climbed by 16.86% to $5.0 billion in 2022, then climbed by 19.53% to $6.0 billion in 2023, then grew by 19.83% to $7.2 billion in 2024.